Esam I Azhar
Esam I Azhar is an expert in Infectiology at King Abdulaziz University (Saudi Arabia). Esam I Azhar has authored 428 publications, the most recent in 2026. SLR score: 1,430 (community average: 125). How the SLR is computed.
LeadR Profile
Infectiology
Subspecialties: Public Health - Biochemistry
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1989 - 2026
Number : 428
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| From El Niño forecasts to proportionate public health action: a forecast-to-action framework for climate-related health risks. PMID 42845914 — climate, public health | Front Public Health | 2026 | 0 |
| ORF2 of hepatitis E virus: genetic and antigenic variation across genotypes and implications for immunity, diagnostics and vaccine development. PMID 42848442 — genetic variation, hepatitis e virus, vaccines, antigenic variation, phenotype, viruses, immunity, genotype, hepatitis e, hepatitis, vaccine development | J Gen Virol | 2026 | 0 |
| Risk factors and mitigation strategies for spillover of MERS-CoV and other infections at the camel-human-interface: Rapid research needs appraisal. PMID 42641532 — zoonoses, risk factors, research, communicable diseases, middle east respiratory syndrome coronavirus, infections | J Infect Public Health | 2026 | 0 |
| Host cell entry receptors as pharmacological targets in respiratory viral infections: from biology to clinical translation. PMID 42682883 — cells, cell biology, influenza, human, viruses, pandemics, therapeutics, seasons, antiviral agents, infections, virus diseases | Front Cell Infect Microbiol | 2026 | 0 |
| Longitudinal Clinical and Molecular Characterization of a Single Pediatric Case of Vertically Acquired HIV-1 Subtype C with Baseline Resistance to Protease Inhibitors. PMID 42654980 — cd4 lymphocyte count, cells, research design, hiv-1, tenofovir, infectious disease transmission, vertical, ritonavir, viral load, hiv, lopinavir, emtricitabine, peptide hydrolases, protease inhibitors, therapeutics, infections, child, abacavir | Microorganisms | 2026 | 0 |
LeadR Networks
Main global connection map